Learning Center for the MDS Foundation
2021 ASH Friday Satellite Symposium

Virtual Symposium
Friday, December 10, 2021
7:00 am – 10:00 am EST

Register Now

ACTIVITY OVERVIEW

The 2021 symposium will describe recent advances in the classification and management of myelodysplastic syndromes.

AGENDA TOPICS

  • While the WHO Classification of MDS has Helped our Patients, We Should Now Move to a Genetically-Inspired Classification
  • When and How Genetic Predisposition to MDS Should be Taken into Account in Clinical Decision Making
  • Can Transplantation Improve Survival Rates For Older Patients with Higher-Risk MDS
  • An Elderly Patient With MDS, Thrombocytopenia, and a Cardiovascular Comorbidity that Requires Anticoagulation or Antiplatelet Therapy
  • A Patient with a Myeloid Neoplasm and a TP53 Mutation
  • An Anemic Patient with CCUS

TARGET AUDIENCE

This activity is designed for an audience of physicians, oncology nurses, nurse practitioners, physician assistants, pharmacists and other health care professionals interested in the treatment and management of patients with Myelodysplastic Syndromes.

LEARNING OBJECTIVES

Upon completion of the educational activity, participants should be able to:

  • Discuss how to use molecular profiling in for the classification and management of MDS
  • Evaluate genetic predisposition in the management of MDS
  • Assess the eligibility for allogeneic stem cell transplantation in older patients with MDS
  • Discuss how to treat elderly patient with MDS, thrombocytopenia, and a cardiovascular comorbidity that requires anticoagulation or antiplatelet therapy
  • Review to treat MDS patients with a TP53 mutation
  • Discuss how to treat an anemic patient with CCUS

FACULTY

Mario Cazzola, MD – Symposium Co-Chair

Professor of Hematology
Department of Molecular Medicine, University of Pavia
Chief, Division of Hematology
Department of Hematology Oncology, Fondazione IRCCS Policlinico S. Matteo
Pavia, Italy

Rena Buckstein, MD – Symposium Co-Chair

Head Hematology Site Group
Co-Director of MDS Research Program
Odette Cancer Center
Toronto, Ontario, Canada

Stephen D. Nimer, MD – MDSF Chairman

Director, Sylvester Comprehensive Cancer Center
Professor of Medicine, Biochemistry & Molecular Biology
University of Miami Miller School of Medicine
Miami, Florida, USA

Rafael Bejar, MD, PhD

Associate Professor
University of California, San Diego
Moores Cancer Center
La Jolla, California, USA

Elsa Bernard, PhD

Memorial Sloan Kettering Cancer Center
New York City, NY USA

Luca Malcovati, MD

Associate Professor of Hematology, University of Pavia and IRCCS S. Matteo Hospital Foundation
Departments of Molecular Medicine & Hematology Oncology
Pavia, Italy

Moshe Mittelman, MD

Director, Department of Medicine
Tel-Aviv Sourasky Medical Center
Tel-Aviv, Israel

Ghulam Mufti, OBE, DM, FRCP, FRCPath, CPath

Professor of Haemato-Oncology
Director of BMS-Celgene & King’s College London Research Programme
King’s College London & King’s College Hospital
Haematological Medicine
London, UK

David Sallman, MD

Assistant Member
H. Lee Moffitt Cancer Center and Research Institute, Inc.
Malignant Hematology Department
Tampa, FL, USA

Zhuoer Xie, MD, MS

Mayo Clinic
Rochester, MN, USA

AGENDA

Co-Chairs: Mario Cazzola, MD (Pavia, Italy), Rena Buckstein, MD (Toronto, Canada)

7:00 – 7:10 am Welcome & Program Overview and Objectives
Stephen Nimer, MD (MDSF Chairman) and Mario Cazzola, MD
7:10 – 7:35 am While the WHO Classification of MDS has Helped our Patients, We Should Now
Move to a Genetically-Inspired Classification

Elsa Bernard, PhD
New York City, New York, USA
7:35 – 8:00 am When and How Genetic Predisposition to MDS Should be Taken into Account in Clinical Decision Making
Luca Malcovati, MD
Pavia, Italy
8:00 – 8:25 am Can Transplantation Improve Survival Rates For Older Patients with Higher-Risk
MDS

Ghulam Mufti, DM, FRCP, FRCPath
London, United Kingdom
8:25 – 8:55 am An Elderly Patient With MDS, Thrombocytopenia, and a Cardiovascular Comorbidity that Requires Anticoagulation or Antiplatelet Therapy
Moshe Mittelman, MD
Tel Aviv, Israel
8:55 – 9:25 am A Patient with a Myeloid Neoplasm and a TP53 Mutation
David Sallman, MD
Miami, Florida, USA
9:25 – 9:55 am An Anemic Patient with CCUS
Zhuoer Xie, MD
Rochester, Minnesota, USA
9:55 – 10:00 am Closing Remarks
Mario Cazzola, MD and Rena Buckstein, MD

CRITERIA FOR SUCCESS

Certificates of completion will be awarded based on the participant’s attendance and submission of the activity evaluation/claim credit form at https://www.mds-foundation.org/learning-center/2021-ash-registration-form/.

You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at tbrignoni@akhcme.com.

ACCREDITATION

Credit provided by AKH Inc., Advancing Knowledge in Healthcare

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and the Myelodysplastic Syndromes Foundation, Inc. (MDSF). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIANS

AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 3 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PHARMACISTS

AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 3 contact hours.

NURSES

3 ANCC contact hours

PHYSICIAN ASSISTANTS

AAPA Credit Designation Statement
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

COMMERCIAL SUPPORT

This activity is supported by an educational grant from Taiho Oncology, Inc. Any additional support received will be disclosed prior to start of activity.

AMERICANS WITH DISABILITIES ACT

AKH Inc, Advancing Knowledge in Healthcare fully intends to comply with the legal requirements of the Americans with Disabilities Act.  If you need assistance, please notify AKH at 904-683-8843 at least two weeks prior to the activity.

*Activity and faculty subject to change

Register Now

**Please note that CME credits will only be available to participants that attend the live symposium.

Message Board
Review answers to commonly asked questions or get answers to your questions from an MDS expert